WMS Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,956
| Closed | -$337K | – | 41 |
|
|
2024
Q4 | $337K | Sell |
5,956
-27
| -0.5% | -$1.51K | 0.02% | 228 |
|
|
2024
Q3 | $310K | Sell |
5,983
-355
| -6% | -$16.7K | 0.02% | 225 |
|
|
2024
Q2 | $263K | Buy |
6,338
+844
| +15% | +$37.8K | 0.02% | 224 |
|
|
2024
Q1 | $298K | Sell |
5,494
-3,370
| -38% | -$172K | 0.02% | 213 |
|
|
2023
Q4 | $455K | Sell |
8,864
-2,624
| -23% | -$138K | 0.03% | 167 |
|
|
2023
Q3 | $667K | Sell |
11,488
-1,997
| -15% | -$122K | 0.05% | 124 |
|
|
2023
Q2 | $862K | Sell |
13,485
-1,447
| -10% | -$97K | 0.07% | 112 |
|
|
2023
Q1 | $1.03M | Sell |
14,932
-2,520
| -14% | -$178K | 0.09% | 93 |
|
|
2022
Q4 | $1.26M | Sell |
17,452
-4,746
| -21% | -$358K | 0.12% | 86 |
|
|
2022
Q3 | $1.58M | Sell |
22,198
-5,560
| -20% | -$403K | 0.21% | 59 |
|
|
2022
Q2 | $2.14M | Sell |
27,758
-1,095
| -4% | -$83.4K | 0.33% | 49 |
|
|
2022
Q1 | $2.11M | Buy |
28,853
+468
| +2% | +$31.4K | 0.29% | 47 |
|
|
2021
Q4 | $1.77M | Sell |
28,385
-2,240
| -7% | -$131K | 0.38% | 47 |
|
|
2021
Q3 | $1.81M | Buy |
30,625
+1,848
| +6% | +$122K | 0.27% | 53 |
|
|
2021
Q2 | $1.92M | Sell |
28,777
-606
| -2% | -$39.5K | 0.28% | 49 |
|
|
2021
Q1 | $1.85M | Sell |
29,383
-330
| -1% | -$20.5K | 0.42% | 44 |
|
|
2020
Q4 | $1.84M | Buy |
29,713
+792
| +3% | +$48.7K | 0.32% | 44 |
|
|
2020
Q3 | $1.74M | Buy |
28,921
+581
| +2% | +$35K | 0.34% | 45 |
|
|
2020
Q2 | $1.67M | Buy |
28,340
+22,182
| +360% | +$1.33M | 0.35% | 43 |
|
|
2020
Q1 | $343K | Buy |
6,158
+4
| +0.1% | +$244 | 0.1% | 127 |
|
|
2019
Q4 | $395K | Buy |
6,154
+500
| +9% | +$28.6K | 0.09% | 152 |
|
|
2019
Q3 | $287K | Buy |
5,654
+1,155
| +26% | +$54.3K | 0.07% | 177 |
|
|
2019
Q2 | $204K | Sell |
4,499
-554
| -11% | -$25.8K | 0.05% | 207 |
|
|
2019
Q1 | $241K | Sell |
5,053
-970
| -16% | -$48.3K | 0.06% | 171 |
|
|
2018
Q4 | $313K | Sell |
6,023
-306
| -5% | -$16.4K | 0.09% | 133 |
|
|
2018
Q3 | $393K | Buy |
6,329
+4
| +0.1% | +$237 | 0.04% | 142 |
|
|
2018
Q2 | $350K | Sell |
6,325
-171
| -3% | -$9.23K | 0.04% | 147 |
|
|
2018
Q1 | $411K | Buy |
6,496
+324
| +5% | +$20.8K | 0.05% | 135 |
|
|
2017
Q4 | $378K | Sell |
6,172
-80
| -1% | -$5K | 0.04% | 157 |
|
|
2017
Q3 | $399K | Sell |
6,252
-36
| -0.6% | -$2.1K | 0.05% | 148 |
|
|
2017
Q2 | $350K | Sell |
6,288
-1,057
| -14% | -$57.5K | 0.04% | 151 |
|
|
2017
Q1 | $399K | Sell |
7,345
-1,126
| -13% | -$61.8K | 0.05% | 135 |
|
|
2016
Q4 | $495K | Sell |
8,471
-392
| -4% | -$21.4K | 0.07% | 109 |
|
|
2016
Q3 | $478K | Buy |
8,863
+3,176
| +56% | +$204K | 0.06% | 115 |
|
|
2016
Q2 | $418K | Buy |
5,687
+690
| +14% | +$48.8K | 0.06% | 130 |
|
|
2016
Q1 | $319K | Sell |
4,997
-770
| -13% | -$48.6K | 0.04% | 151 |
|
|
2015
Q4 | $397K | Buy |
5,767
+799
| +16% | +$52.8K | 0.06% | 136 |
|
|
2015
Q3 | $294K | Sell |
4,968
-2,018
| -29% | -$128K | 0.04% | 155 |
|
|
2015
Q2 | $465K | Sell |
6,986
-1,694
| -20% | -$112K | 0.05% | 178 |
|
|
2015
Q1 | $560K | Buy |
8,680
+859
| +11% | +$53.8K | 0.07% | 155 |
|
|
2014
Q4 | $462K | Buy |
7,821
+830
| +12% | +$46.8K | 0.07% | 122 |
|
|
2014
Q3 | $358K | Hold |
6,991
| – | – | 0.06% | 166 |
|
|
2014
Q2 | $339K | Sell |
6,991
-757
| -10% | -$37.3K | 0.05% | 180 |
|
|
2014
Q1 | $403K | Buy |
7,748
+37
| +0.5% | +$1.97K | 0.06% | 160 |
|
|
2013
Q4 | $410K | Sell |
7,711
-4,633
| -38% | -$236K | 0.07% | 148 |
|
|
2013
Q3 | $571K | Buy |
12,344
+360
| +3% | +$15.8K | 0.11% | 99 |
|
|
2013
Q2 | $536K | Buy |
+11,984
| New | +$520K | 0.1% | 109 |
|
Other funds holding BMY
WMS Partners's BMY Position: Q1 2025 in Review
WMS Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 5,956 shares — an estimated $337K sold.
WMS Partners first reported a position in BMY in Q2 2013 and held it in 47 quarters. The position peaked at $2.14M in Q2 2022. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- WMS Partners reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- WMS Partners sold 5,956 Bristol-Myers Squibb shares in Q1 2025, an estimated $337K.
- WMS Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 47 quarters.
- WMS Partners's Bristol-Myers Squibb position peaked at $2.14M in Q2 2022.
- 2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on WMS Partners's 13F filing for Q1 2025.